Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain.

MLA

Nzila-Mounda, A., et al. “Kenyan Plasmodium Falciparum Field Isolates: Correlation between Pyrimethamine and Chlorcycloguanil Activity in Vitro and Point Mutations in the Dihydrofolate Reductase Domain.” Antimicrobial Agents and Chemotherapy, vol. 42, no. 1, Jan. 1998, pp. 164–69. EBSCOhost, https://doi.org/10.1128/AAC.42.1.164.

APA

Nzila-Mounda, A., Mberu, E. K., Sibley, C. H., Plowe, C. V., Winstanley, P. A., & Watkins, W. M. (1998). Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain. Antimicrobial Agents and Chemotherapy, 42(1), 164–169. https://doi.org/10.1128/AAC.42.1.164

Chicago

Nzila-Mounda, A, E K Mberu, C H Sibley, C V Plowe, P A Winstanley, and W M Watkins. 1998. “Kenyan Plasmodium Falciparum Field Isolates: Correlation between Pyrimethamine and Chlorcycloguanil Activity in Vitro and Point Mutations in the Dihydrofolate Reductase Domain.” Antimicrobial Agents and Chemotherapy 42 (1): 164–69. doi:10.1128/AAC.42.1.164.